Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

3B Future Health Fund S.A. SICAR

About 3B Future Health Fund S.A. SICAR, formerly known as Helsinn Investment Fund S.A., SICAR 3B Future Health Fund is focused on investments in areas of high unmet patient need. Backed by the Helsinn Group, and guided by Helsinn’s core values of quality, integrity and respect, 3B Future Health Fund aims to help companies with innovative technologies to transform new ideas into commercial solutions with the potential to impact health-related quality of life of patients. Drawing on Helsinn’s over 40 years of investment into research and development and commercial expertise, the investment fund selects companies with technologies in a range of areas including cancer therapeutics and diagnostics, cancer supportive care, metabolic and gastrointestinal disorders, and dermatology conditions. *


Period Start 2020-07-14 renamed date ca
  Group Helsinn (Group)
  Predecessor Helsinn Investment Fund S.A., SICAR
Product Industry financial services
Person Person Braglia, Riccardo (Helsinn Healthcare 200602 Managing Director)
Region Region Luxembourg (cl=5)
  Country Luxembourg
  City n. a. 
    Address record changed: 2020-07-14
Basic data Employees n. a.
  Currency USD
  Annual sales 50,000,000 (capital, committed 2016-10-10)
    * Document for �About Section�: iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva.
Record changed: 2021-04-13


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Helsinn (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top